
PeerView Family Medicine & General Practice CME/CNE/CPE Audio Podcast
by PVI, PeerView Institute for Medical Education
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 1 chart position in 1 market.
By chart position
- 🇲🇾MY · Science#116500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
250 to 1.5K🎙 ~2x weekly·359 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
500 to 3K🇲🇾100% - Active Followers
Loyal subscribers who consistently listen
150 to 900
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 30 epsHosts
Not detected.
Recent guests
Recent episodes
Jennifer Chan, MD, MPH - Personalized Interventions in Neuroendocrine Tumors: Applying the Latest Systemic Therapy Evidence to Guide Treatment Decisions in Community-Based Settings
Jul 20, 2026
1h 03m 19s
Hussein Tawbi, MD, PhD - Moving Immunotherapy FORWARD in Melanoma: FOrum on Real-World Applications of Recent Data for Community Practice
Jul 13, 2026
1h 33m 29s
Maximilian Johannes Hochmair, MD / Zosia Piotrowska, MD, MHS - New Kids on the Block in Pretreated Metastatic EGFRm NSCLC: Emerging Strategies to Overcome Resistance
Jul 13, 2026
31m 24s
Philip J. Mease, MD, MACR - Breaking the Burden of Systemic Lupus Erythematosus: Patient Testimonials and Interprofessional Perspectives on New Developments With CAR-T Cell Therapy
Jul 13, 2026
53m 04s
Paul E. Sax, MD / Eileen Scully, MD, PhD - Contemporary HIV Management: Therapeutic Advances and Real-World Approaches to Patient Care
Jul 13, 2026
1h 03m 22s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/20/26 | neuroendocrine tumorssystemic therapy+3 | Jennifer Chan, MD, MPH | PVI, PeerView Institute for Medical EducationNeuroendocrine Cancer Awareness Network+3 | — | neuroendocrine tumorssystemic therapy+5 | Exelixis, Inc. | 1h 03m 19s | ||
| 7/13/26 | ImmunotherapyMelanoma+3 | Hussein Tawbi, MD, PhD | PVI, PeerView Institute for Medical Education | Rahway, NJ, USA | immunotherapymelanoma+5 | Bristol Myers Squibb | 1h 33m 29s | ||
| 7/13/26 | metastatic EGFRm NSCLCemerging strategies+3 | Maximilian Johannes Hochmair, MDZosia Piotrowska, MD, MHS | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | EGFRm NSCLCmetastatic cancer+3 | AstraZeneca | 31m 24s | ||
| 7/13/26 | Systemic Lupus ErythematosusCAR-T Cell Therapy+3 | Philip J. Mease, MD, MACR | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Systemic Lupus ErythematosusCAR-T Cell Therapy+3 | Alnylam Pharmaceuticals, Inc. | 53m 04s | ||
| 7/13/26 | HIV ManagementTherapeutic Advances+3 | Paul E. Sax, MDEileen Scully, MD, PhD | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | HIVpatient care+3 | Merck & Co., Inc. | 1h 03m 22s | ||
| 7/8/26 | Type 2 Diabetes ManagementEvidence-Based Practice+3 | Javier Morales, MD, FACP, FACE | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Type 2 DiabetesHealthcare Professionals+3 | Lilly | 1h 03m 51s | ||
| 7/8/26 | Seronegative Generalized Myasthenia GravisPersonalized Treatment+3 | Neelam Goyal, MDGil I. Wolfe, MD, FAAN | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Myasthenia GravisCME+5 | argenx US, Inc. | 47m 19s | ||
| 7/2/26 | Multiple SclerosisBTK Inhibition+3 | Jiwon Oh, MD, PhD, FRCPCGregory F. Wu, MD, PhD, FAAN | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+3 | — | Multiple SclerosisBTK Inhibition+3 | Genentech | 58m 11s | ||
| 6/25/26 | Type 2 DiabetesBasal Insulin+3 | Athena Philis-Tsimikas, MD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Type 2 DiabetesBasal Insulin+3 | Lilly | 34m 46s | ||
| 6/15/26 | Long-Acting PrEPHealthcare Education+3 | Colleen F. Kelley, MD, MPH | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | Long-Acting PrEPHealthcare Professionals+5 | Gilead Sciences, Inc. | 33m 47s | ||
| 6/5/26 | Polycythemia VeraHepcidin Pathway+3 | Andrew Kuykendall, MD | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Polycythemia VeraHepcidin+5 | Takeda Pharmaceuticals U.S.A., Inc. | 31m 52s | ||
| 5/29/26 | Chronic Spontaneous UrticariaHealthcare Education+3 | Adam Friedman, MD, FAAD | University of CincinnatiAccreditation Council for Continuing Medical Education (ACCME)+1 | — | Chronic Spontaneous UrticariaCME+3 | Novartis Pharmaceuticals Corporation | 55m 16s | ||
| 5/29/26 | cognitive declinedementia risk+3 | Anna Chodos, MD, MPH | PVI, PeerView Institute for Medical EducationBrightFocus Foundation+3 | — | cognitive declinedementia+5 | Lilly | 46m 16s | ||
| 5/29/26 | Inflammatory Bowel DiseaseTL1A Inhibition+4 | Anita Afzali, MD, MPH, MHCM, FACG, AGAFJessica R. Allegretti, MD, MPH, FACG, AGAF+1 | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Inflammatory Bowel DiseaseTL1A Inhibition+5 | Merck & Co., Inc. | 1h 10m 58s | ||
| 5/29/26 | Acute Lymphoblastic LeukemiaBispecific Options+3 | Ibrahim Aldoss, MD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Acute Lymphoblastic Leukemiabispecific therapy+4 | AstraZeneca | 37m 51s | ||
| 5/25/26 | Type 2 DiabetesBasal Insulin+3 | Athena Philis-Tsimikas, MD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Type 2 DiabetesBasal Insulin+5 | Lilly | 1h 08m 39s | ||
| 5/25/26 | RSV PreventionPediatric Care+3 | Asuncion Mejias, MD, PhD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | Rahway, NJ, USA | RSVpediatric+4 | Merck & Co., Inc. | 1h 04m 50s | ||
| 5/25/26 | Alzheimer's DiseaseDetection+4 | Professor Frank Jessen, MD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Alzheimer's DiseaseCME+4 | Lilly | 31m 48s | ||
| 5/12/26 | Transthyretin Cardiac AmyloidosisInternal Medicine+3 | Julie L. Rosenthal, MD, FACCRonald Witteles, MD, FACC | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | Transthyretin Cardiac Amyloidosisinternal medicine+3 | Alnylam Pharmaceuticals, Inc. | 59m 02s | ||
| 5/12/26 | retinal treatmentanti-VEGF therapies+3 | Christina Y. Weng, MD, MBA | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+3 | — | retinal treatmentanti-VEGF+3 | Genentech | 35m 36s | ||
| 5/7/26 | Parkinson's DiseasePsychosis+3 | — | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Parkinson's Diseasepsychosis+5 | ACADIA Pharmaceuticals Inc. | 56m 47s | ||
| 5/7/26 | Restless Legs SyndromeTreatment Guidelines+3 | J. Andrew Berkowski, MD, FAASM | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | Restless Legs Syndrometreatment gaps+5 | Noctrix Health, Inc. | 46m 37s | ||
| 5/7/26 | Psoriasis careOral IL-23 inhibitors+3 | April W. Armstrong, MD, MPH | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | psoriasisIL-23 inhibitors+3 | Johnson & Johnson | 33m 41s | ||
| 5/7/26 | Incretin-based therapiesType 2 diabetes+3 | Jay H. Shubrook, DO, FAAFP, FACOFP | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | incretinType 2 diabetes+3 | Lilly | 1h 25m 04s | ||
| 5/7/26 | Alzheimer's DiseaseAPOE Status+4 | Professor Christopher ChenProfessor Atsushi Iwata, MD, PhD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Alzheimer's DiseaseAPOE+4 | Lilly | 45m 04s |
Showing 25 of 25
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for PeerView Family Medicine & General Practice CME/CNE/CPE Audio Podcast
Peaked at #116 in MY, currently #116 in MY.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| MY | — | #116 | #116 | — |
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.